ID: ALA202182

Max Phase: Preclinical

Molecular Formula: C11H15NO

Molecular Weight: 177.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc(N2CCCCC2)cc1

Standard InChI:  InChI=1S/C11H15NO/c13-11-6-4-10(5-7-11)12-8-2-1-3-9-12/h4-7,13H,1-3,8-9H2

Standard InChI Key:  FJTDDUIPUAXKSP-UHFFFAOYSA-N

Associated Targets(non-human)

Large conductance calcium-activated potassium channel 44 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 177.25Molecular Weight (Monoisotopic): 177.1154AlogP: 2.38#Rotatable Bonds: 1
Polar Surface Area: 23.47Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.31CX Basic pKa: 6.47CX LogP: 2.63CX LogD: 2.58
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.71Np Likeness Score: -0.68

References

1. Power EC, Ganellin CR, Benton DC..  (2006)  Partial structures of ketoconazole as modulators of the large conductance calcium-activated potassium channel (BK(Ca)).,  16  (4): [PMID:16359866] [10.1016/j.bmcl.2005.11.001]

Source